Skip to content

EQT Weighs Sale of Stake in Prosthesis Firm Ottobock

  • Private equity firm working with adviser to study options
  • Owners delayed a planned IPO for Ottobock this summer
A user demonstrates a Paexo Back exoskeleton device at the Ottobock SE & Co. KGaA office in Berlin, Germany.

A user demonstrates a Paexo Back exoskeleton device at the Ottobock SE & Co. KGaA office in Berlin, Germany.

Photographer: Krisztian Bocsi/Bloomberg
Updated on

EQT AB is exploring strategic options for its stake in prosthesis firm Ottobock SE including a potential sale, according to people familiar with the matter. 

The buyout firm is working with JPMorgan Chase & Co. to study various possibilities for its 20% holding in Ottobock, ranging from a sale to initial public offering, the people said, asking not to be identified because the information is private. Any deal could value the business, which is controlled by German billionaire Hans Georg Näder, at more than €5 billion ($5.3 billion), the people said.